{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:38:40Z","timestamp":1794397120976,"version":"4.9.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.healun.2026.04.019","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T14:47:14Z","timestamp":1781189234000},"page":"1357-1374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP)\u00a0definition"],"prefix":"10.1016","volume":"45","author":[{"given":"Fiorella","family":"Calabrese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1908-1739","authenticated-orcid":false,"given":"Benjamin A.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9380-9161","authenticated-orcid":false,"given":"Sean","family":"Agbor-Enoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8409-5646","authenticated-orcid":false,"given":"Christian","family":"Benden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie M.","family":"Budev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam B.","family":"Cochrane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9721-101X","authenticated-orcid":false,"given":"David R.","family":"Darley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3632-5654","authenticated-orcid":false,"given":"Gregory A.","family":"Fishbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0711-6343","authenticated-orcid":false,"given":"Andrew E.","family":"Gelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan R.","family":"Glanville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1422-8367","authenticated-orcid":false,"given":"John R.","family":"Greenland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle J.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Ius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4635-3242","authenticated-orcid":false,"given":"Peter","family":"Jaksch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3582-7580","authenticated-orcid":false,"given":"John O.","family":"Joerns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6232-8560","authenticated-orcid":false,"given":"Hong","family":"Lor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin M.","family":"Lowery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5406-4005","authenticated-orcid":false,"given":"Massimo","family":"Mangiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4661-6471","authenticated-orcid":false,"given":"Letizia Corinna","family":"Morlacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle A.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9173-7607","authenticated-orcid":false,"given":"Arun","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honoria","family":"Ocagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasvir S.","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9598-3369","authenticated-orcid":false,"given":"Elizabeth N.","family":"Pavlisko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Perch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck F.","family":"Rahaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8948-4758","authenticated-orcid":false,"given":"Anja C.","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5962-2184","authenticated-orcid":false,"given":"Laurie","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0638-2586","authenticated-orcid":false,"given":"Stuart","family":"Sweet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9656-5844","authenticated-orcid":false,"given":"Stijn E.","family":"Verleden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary A.","family":"Visner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3468-9251","authenticated-orcid":false,"given":"Robin","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-3095","authenticated-orcid":false,"given":"Kathryn A.","family":"Wikenheiser-Brokamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Zeevi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0708-1937","authenticated-orcid":false,"given":"Ramsey R.","family":"Hachem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2026.04.019_bib1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.healun.2016.01.1223","article-title":"Antibody-mediated rejection of the lung: a\u00a0consensus report of the International Society for Heart and Lung Transplantation","volume":"35","author":"Levine","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.healun.2018.01.1305","article-title":"Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: evidence from cell-free DNA analysis","volume":"37","author":"Agbor-Enoh","year":"2018","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.healun.2022.09.012","article-title":"Clinical features and allograft failure rates of pulmonary antibody-mediated rejection categories","volume":"42","author":"Charya","year":"2023","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib4","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.healun.2013.07.004","article-title":"Acute antibody-mediated rejection after lung transplantation","volume":"32","author":"Witt","year":"2013","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1111\/ajt.14534","article-title":"The role of C4d deposition in the diagnosis of antibody-mediated rejection after lung transplantation","volume":"18","author":"Aguilar","year":"2018","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.trim.2014.06.004","article-title":"Evolving experience of treating antibody-mediated rejection following lung transplantation","volume":"31","author":"Otani","year":"2014","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2026.04.019_bib7","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/ajt.13589","article-title":"Antibody-mediated rejection in lung transplantation: clinical outcomes and donor-specific antibody characteristics","volume":"16","author":"Roux","year":"2016","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.healun.2012.10.007","article-title":"Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation","volume":"32","author":"Lobo","year":"2013","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta2030","article-title":"Consensus development methods, and their use in clinical guideline development","volume":"2","author":"Murphy","year":"1998","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.healun.2026.04.019_bib10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi methodology in healthcare research: How to decide its appropriateness","volume":"11","author":"Nasa","year":"2021","journal-title":"World J Metholdol"},{"key":"10.1016\/j.healun.2026.04.019_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.chest.2022.02.012","article-title":"Screening strategies for pulmonary hypertension in patients with interstitial lung disease: a\u00a0multidisciplinary Delphi study","volume":"162","author":"Rahaghi","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.healun.2026.04.019_bib12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12931-022-02292-3","article-title":"Expert consensus on the management of systemic sclerosis-associated interstitial lung disease","volume":"24","author":"Rahaghi","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.healun.2026.04.019_bib13","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0146-2019","article-title":"Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis","volume":"29","author":"Rahaghi","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.healun.2026.04.019_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.70088","article-title":"Approach to lung transplantation in pulmonary arterial hypertension: a\u00a0Delphi consensus on behalf of the transplant task force of the Pulmonary Vascular Research Institute","volume":"15","author":"Kolaitis","year":"2025","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2026.04.019_bib15","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0147-2019","article-title":"Management of repository corticotrophin infection therapy for pulmonary sarcoidosis: a\u00a0Delphi study","volume":"29","author":"Rahaghi","year":"2020","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.healun.2026.04.019_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12055","article-title":"Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat","volume":"12","author":"Rahaghi","year":"2022","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2026.04.019_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/11795484211006050","article-title":"Delphi consensus recommendations on management of dosing, adverse events, and comorbidities in the treatment of idiopathic pulmonary fibrosis with nintedanib","volume":"15","author":"Rahaghi","year":"2021","journal-title":"Clin Med Insights Circ Respir Pulm Med"},{"key":"10.1016\/j.healun.2026.04.019_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2020.101979","article-title":"An expert panel Delphi consensus statement on patient selection and management for transitioning between oral and inhaled treprostinil","volume":"66","author":"Rahaghi","year":"2021","journal-title":"Pulm Pharm Ther"},{"key":"10.1016\/j.healun.2026.04.019_bib19","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1177\/2045893217721695","article-title":"Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): a\u00a0Delphi consensus document","volume":"7","author":"Rahaghi","year":"2017","journal-title":"Pulm Circ"},{"key":"10.1016\/j.healun.2026.04.019_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12890-020-01209-4","article-title":"Expert consensus on the management of adverse events and prescribing practices associated with the treatment of patients taking pirfenidone for idiopathic pulmonary fibrosis: a\u00a0Delphi consensus study","volume":"20","author":"Rahaghi","year":"2020","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.healun.2026.04.019_bib21","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib23","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1111\/ajt.15687","article-title":"Pseudomonas aeruginosa and acute rejection independently increase the risk of donor-specific antibodies after lung transplantation","volume":"20","author":"Kulkarni","year":"2020","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adp1349","article-title":"Pseudomonas aeruginosa infection induces intragraft lymphocytotoxicity that triggers lung transplant antibody-mediated rejection","volume":"17","author":"Liao","year":"2025","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.healun.2026.04.019_bib25","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/ajt.13192","article-title":"HLA epitopes as viewed by antibodies: what is it all about?","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib26","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/tan.14781","article-title":"Clinical utility of serial serum dilutions for HLA antibody interpretation","volume":"100","author":"Tambur","year":"2022","journal-title":"HLA"},{"key":"10.1016\/j.healun.2026.04.019_bib27","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1111\/ajt.14752","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2017 Working Group Meeting Report","volume":"18","author":"Tambur","year":"2018","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib28","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1111\/ajt.15937","article-title":"Sensitization in transplantation: assessment of risk (STAR) 2019 Working Group Meeting Report","volume":"20","author":"Tambur","year":"2020","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib29","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ajt.2022.11.009","article-title":"Sensitization in transplantation: assessment of risk 2022 working group meeting report","volume":"23","author":"Tambur","year":"2023","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/tri.13149","article-title":"Donor-specific HLA antibody-mediated complement activation is a significant indicator of antibody-mediated rejection and poor long-term graft outcome during lung transplantation: a single center cohort study","volume":"31","author":"Roux","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.healun.2026.04.019_bib31","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01898-2017","article-title":"Role of C1q-binding anti-HLA antibodies as a predictor of lung allograft outcome","volume":"52","author":"Brugiere","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2026.04.019_bib32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.humimm.2017.09.001","article-title":"Comprehensive assessment for serum treatment for single antigen test for detection of HLA antibodies","volume":"78","author":"Zhang","year":"2017","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2026.04.019_bib33","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.healun.2012.09.021","article-title":"Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients","volume":"32","author":"Zeevi","year":"2013","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib34","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1111\/ajt.13295","article-title":"Assessing antibody strength: comparison of MFI, C1q, and titer information","volume":"15","author":"Tambur","year":"2015","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib35","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/his.13823","article-title":"C4d detection and histological patterns in the diagnosis of antibody-mediated rejection after lung transplantation: a single-centre study","volume":"74","author":"Ngo","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.healun.2026.04.019_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3389\/fimmu.2016.00433","article-title":"Antibody subclass repertoire and graft outcome following solid organ transplantation","volume":"7","author":"Valenzuela","year":"2016","journal-title":"Front Immunol"},{"key":"10.1016\/j.healun.2026.04.019_bib37","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/ajt.14229","article-title":"The road to HLA antibody evaluation: do not rely on MFI","volume":"17","author":"Sullivan","year":"2017","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib38","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/ajt.14544","article-title":"Outside-in HLA class I signaling regulates ICAM-1 clustering and endothelial cell-monocyte interactions via mTOR in transplant antibody-mediated rejection","volume":"18","author":"Salehi","year":"2018","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib39","first-page":"S1053","article-title":"Impact of donor specific antibodies on longitudinal lung function and baseline lung allograft dysfunction","author":"Alnabateh","year":"2025","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib40","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.humimm.2019.04.008","article-title":"The impact of non-HLA antibodies on outcomes after lung transplantation and implications for therapeutic approaches","volume":"80","author":"Hachem","year":"2019","journal-title":"Hum Immunol"},{"key":"10.1016\/j.healun.2026.04.019_bib41","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.transproceed.2020.01.126","article-title":"Angiotensin II Type 1 Receptor expression in renal transplant biopsies and Anti-AT1R antibodies in serum indicates the risk of transplant loss","volume":"52","author":"Sas-Strozik","year":"2020","journal-title":"Transpl Proc"},{"key":"10.1016\/j.healun.2026.04.019_bib42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ajt.13915","article-title":"Donor-derived exosomes with lung self-antigens in human lung allograft rejection","volume":"17","author":"Gunasekaran","year":"2017","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.it.2018.04.003","article-title":"Divergent roles of antiself antibodies during infection","volume":"39","author":"Rivera-Correa","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.healun.2026.04.019_bib44","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/MOT.0000000000000811","article-title":"The role of non-HLA antibodies in solid organ transplantation: a complex deliberation","volume":"25","author":"Jackson","year":"2020","journal-title":"Curr Opin Organ Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.healun.2023.12.007","article-title":"Chronic lung allograft dysfunction is associated with an increased number of non-HLA antibodies","volume":"43","author":"Xu","year":"2024","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib46","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.transproceed.2024.11.031","article-title":"Non-HLA antibodies and the risk of antibody-mediated rejection without donor-specific anti-HLA antibodies after lung transplantation","volume":"57","author":"Comins-Boo","year":"2025","journal-title":"Transpl Proc"},{"key":"10.1016\/j.healun.2026.04.019_bib47","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa2408835","article-title":"Microvascular inflammation of kidney allografts and clinical outcomes","volume":"392","author":"Sablik","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2026.04.019_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.healun.2025.08.007","article-title":"Diagnostic significance of intragraft donor-specific anti-HLA antibodies in pulmonary antibody-mediated rejection","volume":"45","author":"Hirschi","year":"2026","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib49","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.healun.2016.06.010","article-title":"Lung intragraft donor-specific antibodies as a risk factor for graft loss","volume":"35","author":"Visentin","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib50","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.TP.0000078895.24606.45","article-title":"Detection of donor-specific anti-HLA antibodies with flow cytometry in eluates and sera from renal transplant recipients with chronic allograft nephropathy","volume":"76","author":"Martin","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2026.04.019_bib51","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1111\/ajt.12438","article-title":"Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome","volume":"13","author":"Bachelet","year":"2013","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib52","article-title":"Antibody-mediated rejection and sponge effect in a redo lung transplant recipient","volume":"2021","author":"Arjuna","year":"2021","journal-title":"Case Rep Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.healun.2015.08.021","article-title":"Banff study of pathologic changes in lung allograft biopsy specimens with donor-specific antibodies","volume":"35","author":"Wallace","year":"2016","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.14990","article-title":"Banff lung report: current knowledge and future research perspectives for diagnosis and treatment of pulmonary antibody-mediated rejection (AMR)","volume":"19","author":"Roux","year":"2019","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib55","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/TP.0000000000002688","article-title":"Alveolar septal widening as an \u201cAlert\u201d signal to look into lung antibody-mediated rejection: a multicenter pilot study","volume":"103","author":"Calabrese","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2026.04.019_bib56","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.healun.2023.10.002","article-title":"Assessing the role of phosphorylated S6 ribosomal protein in the pathological diagnosis of pulmonary antibody-mediated rejection","volume":"43","author":"Lunardi","year":"2024","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib57","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.healun.2021.06.021","article-title":"Phosphorylated S6 ribosomal protein expression by immunohistochemistry correlates with de novo donor-specific HLA antibodies in lung allograft recipients","volume":"40","author":"Cone","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib58","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/j.1600-6143.2006.01355.x","article-title":"Phosphorylated S6 ribosomal protein: a novel biomarker of antibody-mediated rejection in heart allografts","volume":"6","author":"Lepin","year":"2006","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib59","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.healun.2014.09.047","article-title":"Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts","volume":"34","author":"Li","year":"2015","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib60","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1513\/AnnalsATS.201810-713OC","article-title":"Association between allosensitization and waiting list outcomes among adult lung transplant candidates in the United States","volume":"16","author":"Tague","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.healun.2026.04.019_bib61","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04090-2020","article-title":"A virtual crossmatch-based strategy for perioperative desensitisation in lung transplant recipients with pre-formed donor-specific antibodies: 3-year outcome","volume":"58","author":"Parquin","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.healun.2026.04.019_bib62","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/MOT.0000000000000878","article-title":"Desensitization and management of allograft rejection","volume":"26","author":"Zaffiri","year":"2021","journal-title":"Curr Opin Organ Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.trim.2025.102261","article-title":"Efficacy of waitlist desensitization for lung candidates is limited by antibody rebound","volume":"92","author":"Pinelli","year":"2025","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2026.04.019_bib64","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1111\/ajt.16707","article-title":"Long-term outcomes of sensitized lung transplant recipients after peri-operative desensitization","volume":"21","author":"Aversa","year":"2021","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib65","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.ajt.2023.04.033","article-title":"Outcomes after flow cytometry crossmatch-positive lung transplants managed with perioperative desensitization","volume":"23","author":"Aversa","year":"2023","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib66","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/j.ajt.2023.04.034","article-title":"Lung transplantation despite preformed donor-specific antihuman leukocyte antigen antibodies: a\u00a09-year single-center experience","volume":"23","author":"Heise","year":"2023","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib67","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/TP.0000000000004413","article-title":"Safety of crossing donor-specific antibodies in lung transplantation","volume":"107","author":"Wang","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2026.04.019_bib68","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/j.ajt.2025.02.009","article-title":"Perioperative C1-esterase inhibitor therapy to allow transplantation in a highly sensitized lung transplant candidate: three case reports","volume":"25","author":"Devaquet","year":"2025","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib69","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.70241","article-title":"Long-term chronic lung allograft dysfunction-free survival following lung transplant in the presence of donor-specific antibodies","volume":"39","author":"Grobman","year":"2025","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib70","doi-asserted-by":"crossref","first-page":"410","DOI":"10.21037\/atm.2020.02.127","article-title":"Surveillance for acute cellular rejection after lung transplantation","volume":"8","author":"Greer","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.healun.2026.04.019_bib71","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive monitoring of infection and rejection after lung transplantation","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.healun.2026.04.019_bib72","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.healun.2021.04.009","article-title":"Donor-derived cell-free DNA accurately detects acute rejection in lung transplant patients, a multicenter cohort study","volume":"40","author":"Jang","year":"2021","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib73","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.healun.2021.12.009","article-title":"Donor-derived cell-free DNA as a composite marker of acute lung allograft dysfunction in clinical care","volume":"41","author":"Keller","year":"2022","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib74","first-page":"S1600","article-title":"Donor-derived cell-free DNA is associated with the degree of immunosuppression in lung transplantation","author":"Charya","year":"2025","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib75","first-page":"S1053","article-title":"Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure","author":"Keller","year":"2025","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib76","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1600-6143.2008.02467.x","article-title":"Pulmonary capillaritis as a manifestation of acute humoral allograft rejection following infant lung transplantation","volume":"9","author":"Astor","year":"2009","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib77","first-page":"508","article-title":"Antibody-mediated rejection in lung transplantation: case reports","author":"Girnita","year":"2006","journal-title":"Clin Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib78","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.trim.2012.08.002","article-title":"Antibody-mediated rejection in a lung transplant recipient after acute stroke","volume":"27","author":"Hayes","year":"2012","journal-title":"Transpl Immunol"},{"key":"10.1016\/j.healun.2026.04.019_bib79","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jca.21270","article-title":"Measurement of donor-specific HLA antibodies following plasma exchange therapy predicts clinical outcome in pediatric heart and lung transplant recipients with antibody-mediated rejection","volume":"28","author":"Jackups","year":"2013","journal-title":"J Clin Apher"},{"key":"10.1016\/j.healun.2026.04.019_bib80","first-page":"137","article-title":"Diagnosis and management of antibody-mediated rejection following pediatric lung transplantation","volume":"7","author":"Astor","year":"2013"},{"key":"10.1016\/j.healun.2026.04.019_bib81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/ajt.16862","article-title":"CTOTC-08: A multicenter randomized controlled trial of rituximab induction to reduce antibody development and improve outcomes in pediatric lung transplant recipients","volume":"22","author":"Sweet","year":"2022","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib82","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.healun.2025.09.016","article-title":"Considerations for endpoints in lung transplant clinical trials: an ISHLT consensus statement","volume":"45","author":"Greenland","year":"2026","journal-title":"J Heart Lung Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib83","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ajt.2022.10.006","article-title":"CD16+ natural killer cells in bronchoalveolar lavage are associated with antibody-mediated rejection and chronic lung allograft dysfunction","volume":"23","author":"Calabrese","year":"2023","journal-title":"Am J Transpl"},{"key":"10.1016\/j.healun.2026.04.019_bib84","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.kint.2023.11.012","article-title":"Transcriptomic signatures of chronic active antibody-mediated rejection deciphered by RNA sequencing of human kidney allografts","volume":"105","author":"Shah","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.healun.2026.04.019_bib85","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/thoraxjnl-2018-212345","article-title":"Natural killer cells in lung transplantation","volume":"74","author":"Calabrese","year":"2019","journal-title":"Thorax"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249826018656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249826018656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:19:13Z","timestamp":1794395953000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249826018656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":85,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S1053249826018656"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2026.04.019","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP)\u00a0definition","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2026.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society for Heart and Lung Transplantation.","name":"copyright","label":"Copyright"}]}}